Salbutamol Oral Liquid Market Report 2026

Salbutamol Oral Liquid Market Overview

• Salbutamol Oral Liquid market size has reached to $1.17 billion in 2025 • Expected to grow to $1.52 billion in 2030 at a compound annual growth rate (CAGR) of 5.3% • Growth Driver: Increasing Incidences Of Respiratory Disorders Fueling The Growth Of The Market Due To Rising Demand For Effective Bronchodilators • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Salbutamol Oral Liquid Market?

Salbutamol oral liquid refers to a medication formulation containing salbutamol, a bronchodilator that helps relax the muscles in the airways. It is used for the relief and prevention of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD). The main product types of salbutamol oral liquid are oral liquid solutions and oral liquid suspensions. Salbutamol oral liquid solutions are bronchodilator medications in liquid form, primarily used to relieve symptoms of asthma, bronchitis, and other obstructive airway diseases by relaxing the muscles in the airways and improving airflow to the lungs. These formulations include syrup, solution, and concentrate and contain active ingredients such as albuterol, levalbuterol, pirbuterol, salmeterol, and formoterol. Salbutamol oral liquids are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies, and are used in applications such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

What Is The Salbutamol Oral Liquid Market Growth Forecast?

The salbutamol oral liquid market size is expected to see strong growth in the next few years. It will grow to $1.52 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to development of advanced oral liquid suspensions, growing online pharmacy penetration, rising pediatric and geriatric patient base, expansion of multi-ingredient respiratory formulations, increasing regulatory compliance and quality certifications. Major trends in the forecast period include rising prevalence of asthma and copd, increasing demand for pediatric and geriatric formulations, expansion of hospital and retail pharmacy channels, growth in online pharmacy and e-commerce distribution, focus on preservative-free and patient-friendly formulations.

Global Salbutamol Oral Liquid Market Segmentation

1) By Product Type: Oral Liquid Solutions, Oral Liquid Suspensions 2) By Formulation Type: Syrup, Solution, Concentrate 3) By Ingredient: Albuterol, Levalbuterol, Pirbuterol, Salmeterol, Formoterol 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 5) By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Other Respiratory Conditions Subsegments: 1) By Oral Liquid Solutions: Syrup, Solution, Concentrate 2) By Oral Liquid Suspensions: Suspension With Preservatives, Suspension Without Preservatives

What Are The Drivers Of The Salbutamol Oral Liquid Market?

Increasing incidences of respiratory disorders are expected to propel the growth of the salbutamol oral liquid market going forward. Respiratory disorders are medical conditions that affect the lungs and airways, impairing breathing and oxygen exchange in the body. Rising incidences of respiratory disorders are largely due to increasing air pollution and environmental pollutants. Salbutamol oral liquid is used in respiratory disorders to relax airway muscles, ease bronchospasms, and improve airflow, thereby relieving symptoms such as wheezing, shortness of breath, and chest tightness. For instance, in October 2025, according to the Australian Bureau of Statistics, an Australia-based government agency, deaths involving influenza increased from 611 deaths in 2023 to 806 deaths in 2024 and further to 1,057 deaths in the year to August 2025, representing a 73% increase from 2023 to the comparable August 2025 period. Deaths involving respiratory syncytial virus (RSV) rose from 380 deaths in 2023 to 468 deaths in 2024 and 399 deaths in the year to August 2025. Therefore, increasing incidences of respiratory disorders are driving the growth of the salbutamol oral liquid industry. The rise in healthcare expenditures is expected to propel the growth of the salbutamol oral liquid market going forward. Healthcare expenditures refer to the total amount of money spent on healthcare services and products, including hospital care, physician services, medications, and public health initiatives. Increasing healthcare expenditures are often driven by the rising costs of advanced medical technologies and treatments. Increasing healthcare expenditures can be beneficial for salbutamol oral liquid by improving access to essential respiratory medications, supporting widespread diagnosis and treatment of asthma and COPD, and enabling healthcare systems to stock and distribute such bronchodilators more effectively, especially in low-resource settings. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure experienced a significant rise of 5.6% in nominal terms from 2022 to 2023, marking a notable acceleration from the 0.9% growth recorded in 2022. Therefore, the rise in healthcare expenditures is driving the growth of the salbutamol oral liquid industry. The rise in air pollution is expected to propel the growth of the salbutamol oral liquid market going forward. Air pollution is the presence of harmful substances in the air that can negatively affect human health, the environment, and the climate. The increasing air pollution is primarily due to the rising emissions from industrial activities and the burning of fossil fuels. Salbutamol oral liquid is used to relieve breathing difficulties caused by air pollution by relaxing the muscles in the airways and improving airflow to the lungs. For instance, in August 2025, according to the Energy Policy Institute at the University of Chicago (EPIC), a US-based interdisciplinary research institute, 2023 data reveals that global particulate matter in the air concentrations in 2023 were 1.5 percent higher than in 2022. Therefore, a rise in air pollution is driving the growth of the salbutamol oral liquid industry.

Key Players In The Global Salbutamol Oral Liquid Market

Major companies operating in the salbutamol oral liquid market are GlaxoSmithKline plc, Cipla Limited, Lupin Limited, Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Limited, Beta Healthcare International Limited, Sakar Healthcare Limited, Pharmatec Pakistan (Private) Limited, Infinity Pharma, Azaria Pharmaceutical Laboratories Inc., Salvavidas Pharmaceutical Private Limited, Lucky Pharmaceuticals, Wellona Pharma, Centurion Healthcare Private Limited, Niksan Pharmaceutical, SUNWARD PHARMACEUTICAL SDN. BHD., Glumex Pharmaceuticals Mfg. Pvt. Ltd., Indo Rama Engineers, Elikem Pharmaceuticals Private Limited, CCI Products.

Regional Insights

North America was the largest region in the salbutamol oral liquid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Salbutamol Oral Liquid Market?

The salbutamol oral liquid market consists of sales of ventolin syrup, asthalin syrup, salbetol syrup, bronkotab syrup, salbulin syrup, ventair syrup. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Salbutamol Oral Liquid Market Report 2026?

The salbutamol oral liquid market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the salbutamol oral liquid industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.